Dinucleotide repeat polymorphism in Fms-like tyrosine kinase-1 (Flt-1) gene is not associated with preeclampsia
Open Access
- 17 July 2008
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 9 (1), 1-6
- https://doi.org/10.1186/1471-2350-9-68
Abstract
Background: Preeclampsia is a major cause of maternal and perinatal mortality and morbidity. The etiology of preeclampsia remains unclear. Recently, it was shown that misregulation of fms-like tyrosine kinase-1 (Flt-1) in the peripheral blood mononuclear cells of pregnant women results in over-expression of the soluble splice variant of Flt-1, sFlt-1, producing an additional (extra-placental) source of sFlt-1 that can contribute to the etiology of preeclampsia. The aim of this study was to investigate the relationship between preeclampsia and a dinucleotide (threonine-glycine; TG)n repeat polymorphism in the 3' non-coding region of the Flt-1 gene. Methods: The number of the d(TG)n repeats was analyzed in 170 patients with preeclampsia and in 202 normotensive pregnancies. The region containing the dinucleotide repeat polymorphism of the Flt-1 gene was amplified by polymerase chain reaction (PCR) from the DNA samples and was analyzed by direct PCR sequencing. Results: We found 10 alleles of the dinucleotide repeat polymorphism and designated these as allele*12 (A1) through allele*23 (A12) according to the number of the TG repeats, from 12 to 23. The frequency of the 14-repeat allele (A3) was most abundant (63.82% in preeclampsia and 69.06% in controls), followed by the 21-repeat allele (A10; 28.53% in preeclampsia and 23.76% in controls). There was no significant difference in the allele frequency between patients with preeclampsia and normal controls. The most common genotype in preeclamptic and normotensive pregnancies was heterozygous (TG)14/(TG)21 (41.76%) and homozygous (TG)14/(TG)14 (45.05%), respectively. However, the genotype frequencies were not significantly different between preeclamptic patients and controls. Conclusion: This is the first study to characterize the dinucleotide repeat polymorphism of the Flt-1 gene in patients with preeclampsia. We found no differences in the allele or genotype frequencies between patients with preeclampsia and normal pregnancies. Although limited by a relatively small sample size, our study suggests that the d(TG)n repeat polymorphism of the Flt-1 gene is not associated with the development of preeclampsia in Korean pregnant women.Keywords
This publication has 34 references indexed in Scilit:
- Microsatellites: Evolution and Mutational ProcessesPublished by Wiley ,2007
- Increased sFlt-1 to PlGF Ratio in Women Who Subsequently Develop PreeclampsiaJournal of Korean Medical Science, 2007
- Placental Debris, Oxidative Stress and Pre-eclampsiaPlacenta, 2000
- Evidence for a role of phospholipase C-γ1 in the pathogenesis of bipolar disorderMolecular Psychiatry, 1998
- The preterm prediction study: Risk factors for indicated preterm birthsAmerican Journal of Obstetrics and Gynecology, 1998
- Coding versus intron variability: extremely polymorphic HLA-DRB1 exons are flanked by specific composite microsatellites, even in distant populationsHuman Genetics, 1997
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Dinucleotide repeat polymorphism in the 3′ non-coding region of the FLTI geneHuman Molecular Genetics, 1993
- Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proceedings of the National Academy of Sciences, 1993
- Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues.Journal of Clinical Investigation, 1992